4 ms·

> Anti-vax stance is a self correcting problem. Natural immunity is long and strong baby. You'll be waiting a while.

falcolas 5y ago
"... researchers looking at SARS-CoV-2 antibodies in people who had recovered found that the difference between the highest and lowest levels varied by a factor of over 1,000. The researchers saw even more variability when they looked at neutralizing antibodies—those known to bind to the virus and prevent it from infecting cells. Neutralizing antibody levels in recovered people varied over a range of 40,000-fold, and up to 20 percent of people didn't have any detectable level of neutralizing antibody." https://arstechnica.com/science/2020/06/antibody-testing-suggests-immune-response-post-covid-is-very-variable/ https://arstechnica.com/science/2020/06/antibody-testing-sug... But hey, don't let mere science stand in the way of a good catchphrase. EDIT: I'm quite aware I won't change anybody's opinions. I'm also aware that providing opposing evidence will even strengthen beliefs. So, yeah, I shouldn't have risen to the bait. Regardless, good luck!
- peteradio 5y ago
  Serology studies are you kidding me right now? We can and have measured the clinical outcomes. edit: It's pretty rich to hear that you've taken my bait, "self-correcting problem" was masterful baiting.
  - fn-mote 5y ago
    This would be a lot more constructive if you included a link. Or at least explained more. Not everyone reading will have the same background you do, especially when the issue is something technical like discounting a serology study because you know of more convincing ones.
    - xyzzy123 5y ago
      https://www.reuters.com/business/healthcare-pharmaceuticals/prior-covid-infection-more-protective-than-vaccination-during-delta-surge-us-2022-01-19/ https://www.reuters.com/business/healthcare-pharmaceuticals/... There's a lot of talk of antibodies because researchers studying vaccine effectiveness prior to everyone being exposed need something to measure. It's hard to measure the overall effectiveness of a person's immune response, so they measure antibodies, which are not the whole story. It might not even be the important part. I think this is why GP is derisive of serology. The immune system is quite complicated. Personally I suspect that advising people who had breakthrough infections to keep getting boosters will turn out to be bad advice. We'll see I guess.
- jaywalk 5y ago
  Your article is from June 2020. Believe it or not, we have more data now!

"... researchers looking at SARS-CoV-2 antibodies in people who had recovered found that the difference between the highest and lowest levels varied by a factor of over 1,000. The researchers saw even more variability when they looked at neutralizing antibodies—those known to bind to the virus and prevent it from infecting cells. Neutralizing antibody levels in recovered people varied over a range of 40,000-fold, and up to 20 percent of people didn't have any detectable level of neutralizing antibody." https://arstechnica.com/science/2020/06/antibody-testing-suggests-immune-response-post-covid-is-very-variable/ https://arstechnica.com/science/2020/06/antibody-testing-sug... But hey, don't let mere science stand in the way of a good catchphrase. EDIT: I'm quite aware I won't change anybody's opinions. I'm also aware that providing opposing evidence will even strengthen beliefs. So, yeah, I shouldn't have risen to the bait. Regardless, good luck!

peteradio 5y ago
Serology studies are you kidding me right now? We can and have measured the clinical outcomes. edit: It's pretty rich to hear that you've taken my bait, "self-correcting problem" was masterful baiting.
- fn-mote 5y ago
  This would be a lot more constructive if you included a link. Or at least explained more. Not everyone reading will have the same background you do, especially when the issue is something technical like discounting a serology study because you know of more convincing ones.
  - xyzzy123 5y ago
    https://www.reuters.com/business/healthcare-pharmaceuticals/prior-covid-infection-more-protective-than-vaccination-during-delta-surge-us-2022-01-19/ https://www.reuters.com/business/healthcare-pharmaceuticals/... There's a lot of talk of antibodies because researchers studying vaccine effectiveness prior to everyone being exposed need something to measure. It's hard to measure the overall effectiveness of a person's immune response, so they measure antibodies, which are not the whole story. It might not even be the important part. I think this is why GP is derisive of serology. The immune system is quite complicated. Personally I suspect that advising people who had breakthrough infections to keep getting boosters will turn out to be bad advice. We'll see I guess.
jaywalk 5y ago
Your article is from June 2020. Believe it or not, we have more data now!